Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
13+ hour, 24+ min ago (244+ words) When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is that not only is this terrible for patient health, it can be more costly in…...
Better Models Won???t Fix Pharma???s AI Problem??? Better Terminology Will
13+ hour, 25+ min ago (952+ words) At a life sciences conference earlier this year, a pharma analytics lead pulled me aside with what sounded like a simple question: “Is there an ICD-10 code for the disease we’re studying?” There wasn’t. As many researchers know, the reality…...
Patient Group Sues AMA, Says the Org Shouldn???t Be Charging for CPT Codes
2+ day, 5+ hour ago (576+ words) PatientRightsAdvocate.org sued the American Medical Association this week, arguing the trade group has no valid copyright over the CPT codes that providers must use to bill for care. It follows a public letter Senator Bill Cassidy sent to the…...
Aligned Marketplace Secures $20M for Advanced Primary Care Marketplace
2+ day, 6+ hour ago (276+ words) Venrock led Aligned Marketplace's Series A round. In total, the company has raised $31 million to date. Aligned Marketplace, an advanced primary care marketplace, announced Thursday that it secured $20 million in Series A funding, which it will use to reach more…...
Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple Myeloma
2+ day, 7+ hour ago (330+ words) Bristol Myers Squibb’s Zenbexus is the first FDA-approved drug in a new class of cancer drugs called CELMoDs. The pharma company is positioning this molecule as a successor to its legacy products for multiple myeloma. A Bristol Myers Squibb drug…...
Healthcare Keeps Buying AI. But Nobody???s Building the Workforce to Run It.
2+ day, 13+ hour ago (559+ words) Healthcare has spent the past several years talking about artificial intelligence as though the biggest challenge is technological capability. Every week seems to bring another breakthrough model, another pilot program, another promise that AI will finally solve healthcare’s efficiency, workforce,…...
Appeals Court Sides with Providers in No Surprises Act Pay Dispute
3+ day, 3+ hour ago (550+ words) A court ruling struck down key parts of how regulators calculate the No Surprises Act's qualifying payment amount, siding with the Texas Medical Association's argument that the formula has historically favored payers in arbitration. This week, payers lost a major…...
Cotiviti Launches AI Solution to Address Coordination of Benefits Issues
3+ day, 4+ hour ago (388+ words) Cotiviti launched an AI-powered coordination of benefits solution that uses enrollment data to identify and resolve coverage issues before claims are submitted. Cotiviti, a healthcare infrastructure company, launched a new AI-powered coordination of benefits solution on Thursday to support payers....
PTC Therapeutics??? $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
3+ day, 7+ hour ago (396+ words) Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction win brings a Sangamo gene therapy candidate for Fabry disease, a rare inherited disorder…...
Founders Should Stop Worrying If They???re???AI Enough???
3+ day, 12+ hour ago (439+ words) Everybody wants to be “AI-first” because the market is telling them they need to be. But what is AI-first? Is it AI-native? Is it software that has successfully threaded AI across its business? I’m not sure anyone can confidently answer…...